Edition:
United States

AnaptysBio Inc (ANAB.OQ)

ANAB.OQ on NASDAQ Stock Exchange Global Select Market

90.21USD
4:00pm EDT
Change (% chg)

$2.13 (+2.42%)
Prev Close
$88.08
Open
$87.80
Day's High
$90.67
Day's Low
$86.82
Volume
96,235
Avg. Vol
128,182
52-wk High
$134.00
52-wk Low
$33.57

Chart for

About

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)

Overall

Beta: --
Market Cap(Mil.): $2,117.13
Shares Outstanding(Mil.): 24.04
Dividend: --
Yield (%): --

Financials

  ANAB.OQ Industry Sector
P/E (TTM): -- 108.51 32.45
EPS (TTM): -1.62 -- --
ROI: -18.10 1.61 12.63
ROE: -18.80 0.35 14.80

BRIEF-Anaptysbio Qtrly Loss Per Share $0.63

* ANAPTYSBIO ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES PIPELINE UPDATES

May 08 2018

BRIEF-Anaptysbio Announces Positive Top-Line Proof-Of-Concept Data For ANB020 In Moderate-To-Severe Baseline Adult Peanut Allergy Patients

* ANAPTYSBIO ANNOUNCES POSITIVE TOP-LINE PROOF-OF-CONCEPT DATA FOR ANB020 IN MODERATE-TO-SEVERE BASELINE ADULT PEANUT ALLERGY PATIENTS

Mar 26 2018

Earnings vs. Estimates